Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · Real-Time Price · USD

4.480

-0.240 (-5.08%)

At close: Aug 13, 2026, 4:00 PM EDT

4.450

-0.030 (-0.67%)

After-hours: Aug 13, 2026, 7:34 PM EDT

Seres Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-22.46	5.7	0.14	-113.72	-250.16	-65.58
Depreciation & Amortization	3.45	4.13	5.47	6.24	6.63	5.95
Stock-Based Compensation	9.19	10.84	20.97	34.1	25.48	20.22
Other Adjustments	14.27	8.23	-109.68	15	7.62	4.57
Change in Receivables	-24.39	1.55	-2.07	-	-	-
Changes in Inventories	-	-	-33.8	-29.65	-	9.39
Changes in Accounts Payable	-1.01	-2.4	-2.94	-11.58	2.2	9.36
Changes in Accrued Expenses	-11.99	-20.98	-25.9	15.84	3.34	43.03
Changes in Unearned Revenue	-	-	-4.12	6.41	-7.13	-4.36
Changes in Other Operating Activities	-18.31	-5.95	3.32	-40	-16.8	-15.89
Operating Cash Flow	-51.26	1.12	-148.61	-117.35	-228.82	6.69
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-0.04	-0.25	-0.38	-7.98	-9.82	-9.57
Sale of Property, Plant & Equipment	0.21	0.21	-	-	-	-
Purchases of Investments	-	-	-	-4.43	-48.22	-95.97
Proceeds from Sale of Investments	-	-	1.4	22.98	140.47	169.63
Proceeds from Business Divestments	-	-	141.27	-	-	-
Investing Cash Flow	0.19	-0.04	142.29	10.58	82.43	64.09
Long-Term Debt Issued	-	-	-	103.38	27.61	-
Long-Term Debt Repaid	-	-	-127.91	-52.86	-1.91	-0.95
Net Long-Term Debt Issued (Repaid)	-	-	-127.91	50.52	25.7	-0.95
Issuance of Common Stock	14.36	13.9	37.53	21.19	103.9	2.13
Net Common Stock Issued (Repurchased)	14.36	13.9	37.53	21.19	103.9	2.13
Financing Cash Flow	14.86	13.9	-90.37	71.71	129.6	1.18
Foreign Exchange Rate Adjustments	-	-	-0	0	-0	-0
Net Cash Flow	-36.21	14.97	-96.69	-35.07	-16.79	71.95
Free Cash Flow	-51.3	0.87	-148.99	-125.33	-238.64	-2.88
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-2724.11%	109.63%	-	-	-	-1.99%
Free Cash Flow Per Share	-5.49	0.10	-19.18	-19.58	-44.16	-0.63
Levered Free Cash Flow	-43.23	-19.75	-186.12	-123.92	-109.61	-28.62
Unlevered Free Cash Flow	-111.93	-119.42	-179.67	-255.81	-216.68	-26.58

SEC Filings: 10-K · 10-Q